Akèy › Lekemi miyomonositik jivenil
Etid klinik pou Lekemi miyomonositik jivenil ap rekrite nan Etazini
9 etid pou Lekemi miyomonositik jivenil ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Philadelphia, PA4 etid
- Minneapolis, MN4 etid
- Boston, MA3 etid
- Seattle, WA3 etid
- Memphis, TN3 etid
- Cincinnati, OH3 etid
- Atlanta, GA3 etid
- Chicago, IL3 etid
- Washington, DC3 etid
- Ann Arbor, MI3 etid
- San Francisco, CA3 etid
- New York City, NY3 etid
- Indianapolis, IN3 etid
Pa eta
- Colorado3 etid
- Distrik Columbia3 etid
- Florid3 etid
- Georgia3 etid
- Illinois3 etid
- Indiana3 etid
- Kalifòni3 etid
- Massachusetts3 etid
- Michigan3 etid
- Minnesota4 etid
- Missouri3 etid
- New York3 etid
- Ohio3 etid
- Pennsylvania4 etid
- Tennessee3 etid
- Texas3 etid
- Washington3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
Ap rekriteFaz 1/2
1 Month – 21 Years · Tout sèks · Mizajou Sep 4, 2026 · NCT05849662A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
Ap rekriteFaz 1
Laj 1 a 18 · Tout sèks · Mizajou Aug 25, 2026 · NCT06247787The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Ap rekriteFaz 1/2
Jiska laj 22 · Tout sèks · Mizajou Aug 25, 2026 · NCT04726241CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
Ap rekrite
Jiska laj 25 · Tout sèks · Mizajou Jul 8, 2026 · NCT03810196Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Ap rekriteFaz 2
Jiska laj 60 · Tout sèks · Mizajou Jun 25, 2026 · NCT03314974A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
Ap rekriteFaz 1
Laj 12 ak plis · Tout sèks · Mizajou Jun 17, 2026 · NCT04024761Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
Ap rekriteFaz 2
6 Months – 39 Years · Tout sèks · Mizajou Jun 4, 2026 · NCT05800210HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Ap rekriteFaz 1
Jiska laj 80 · Tout sèks · Mizajou May 18, 2026 · NCT03326921MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Ap rekriteFaz 2
Jiska laj 60 · Tout sèks · Mizajou Apr 6, 2026 · NCT05735717Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.